Abstract ALS (Amyotrophic Lateral Sclerosis) is a fatal neurodegenerative disease of the human motor system. It is a group of progressive diseases that affects the nerve cells in the brain and spinal cord that control the muscle movement of the body hence, detection and classification of ALS at the right time is considered to be one of the vital aspects that can save the life of humans. Therefore, in various studies, different AI techniques are used for the detection of ALS, however, these methods are considered to be ineffectual in terms of identifying the disease due to the employment of ineffective algorithms. Hence, the proposed model utilizes Modified Principal Component Analysis (MPCA) and Modified Random Forest (MRF) for performing dimensionality reduction of all the potential features considered for effective classification of the ALS presence and absence of ALS causing mutation in the corresponding gene. The MPCA is adapted for capturing all the Low-Importance Data transformation. Furthermore, The MPCA is objected to performing three various approaches: Covariance Matrix Correlation, Eigen Vector- Eigenvalue decomposition, and selecting the desired principal components. This is done in aspects of implying the LI (Lower-Importance) Data Transformation. By choosing these potential components without any loss of features ensures better viability of selecting the attributes for ALS-causing gene classification. This is followed by the classification of the proposed model by using Modified RF by updating the clump detector technique. The clump detector is proceeded by clustering approach using K-means, and the data reduced by their dimension are grouped accordingly. These clustered data are analyzed either for ALS causing or devoid of causing ALS. Finally, the model’s performance is assessed using different evaluation metrics like accuracy, recall, F1 score, and precision, and the proposed model is further compared with the existing models to assess the efficacy of the proposed model.
amyotrophic lateral sclerosismodified principal component analysisdimensionality reductionK-means clustering
The limitations of the current vaccination strategy for the Kyasanur Forest Disease virus (KFDV) underscore the critical need for effective antiviral treatments, highlighting the crucial importance of exploring novel therapeutic approaches through in silico drug design. Kyasanur Forest Disease, caused by KFDV, is a tick-borne disease with a mortality of 3-5% and an annual incidence of 400 to 500 cases. In the early stage of infection, the envelope protein plays a crucial role by facilitating host-virus interactions. The objective of this research is to develop effective antivirals targeting the envelope protein to disrupt the virus-host interaction. In line with this, the 3D structure of the envelope protein was modeled and refined through molecular modeling techniques, and subsequently, ligands were designed via de novo design and pharmacophore screening, yielding 12 potential hits followed by ADMET analysis. The top five candidates underwent geometry optimization and molecular docking. Notably, compounds L4 (SA28) and L3 (CNP0247967) are predicted to have significant binding affinities of -8.91 and -7.58 kcal/mol, respectively, toward the envelope protein, based on computational models. Both compounds demonstrated stability during 200 ns molecular dynamics simulations, and the MM-GBSA binding free-energy values were -85.26 ± 4.63 kcal/mol and -66.60 ± 2.92 kcal/mol for the envelope protein L3 and L4 complexes, respectively. Based on the computational prediction, it is suggested that both compounds have potential as drug candidates for controlling host-virus interactions by targeting the envelope protein. Further validation through in-vitro assays would complement the findings of the present in silico investigations.
Kyasanur forest disease virusenvelope proteinantiviral drug designhost-virus interaction
Advances in information security, privacy, and ethics book series · 128-144
The chapter explores the critical aspects of data privacy and compliance within the rapidly expanding field of the internet of things (IoT). As IoT devices proliferate across consumer, industrial, and healthcare sectors, they bring with them significant challenges related to data security, privacy, and regulatory compliance. The integration of these devices into daily life raises substantial concerns about personal privacy, data breaches, and the ethical use of collected data. This discussion delves into the mechanisms IoT uses to collect, process, and store data; the associated privacy risks; and the comprehensive strategies necessary to mitigate these risks while ensuring compliance with global data protection regulations.
Internet of Thingsdata privacyregulatory compliancedata protection regulation
Frontiers in Pharmacology · مجلد 15 · 1361679-1361679
Introduction The members retinoic acid receptors (RARs) (α, β, and γ) and retinoid X receptors (RXRs) (α, β, and γ) belong to the retinoid receptor family. They regulate the biological action of classical retinoids through nuclear retinoid receptors, a transcription factor that is regulated by ligands. Through the binding of particular retinoic acid-responsive elements (RAREs) located in target gene promoters, RARs and members of the RXRs form heterodimers. By binding to its nuclear receptors and triggering the transcription of the target genes downstream, retinoic acid (RA) mediates the expression of certain genes. Retinoids so mainly control gene expression to carry out their biological actions. RARs are essential for many biological processes, such as development, immunity, reproduction, organogenesis, and homeostasis. Apart from their physiological functions, RARs are also linked to pathologies and tumors due to mutations, protein fusions, changes in expression levels, or abnormal post-translational changes that lead to aberrant functions and homeostasis breakdown. The oncogenic development of animal tissues or cultured cells is linked to altered expression of retinoid receptors. The RAR-α is over-expressed in several malignancies. Increased invasion and migration in several cancer forms, including HNSC carcinoma, pediatric low-grade gliomas, lung adenocarcinoma, and breast cancer, have been linked to its upregulated expression. Numerous approved therapeutic regimens targeting RAR-α have been developed, improving patient survival rates. Objective This study’s main objective was to identify novel RAR-α-targeting drugs and evaluate the expression patterns of RAR-α in breast cancer patients. Methodology In-silico investigation using a variety of bioinformatics tools like UALCAN, TISCH, TIMER 2.0, ENRICHR, and others were employed to examine the expression of RAR-α. Further we evaluated in-silico inhibition of RAR-α with trifarotene and also tested the cytotoxicity of trifarotene in breast cancer cells. Results Our research indicates that RAR-α is upregulated in several malignancies including Breast Cancer. It regulates granulocyte differentiation and has an association with the retinoic acid receptor signaling pathway and cellular response to estrogen stimulus. Furthermore, trifarotene was found as a potential synthetic compound that targets RAR-α through in silico and in-vitro study. Discussion Overall, this research indicates that elevated expression of RAR-α enhances the onset of breast cancer. Using trifarotene medication to target RAR-α will significantly boost the response of breast cancer individuals to treatment and delay the development of resistance to drugs.
RARαretinoic acid receptor alphatrifarotenebreast cancer
Arabian Journal of Chemistry · مجلد 17 (7) · 105837-105837
There are very limited analytical procedures to determine lemborexant (LMB) in dosage forms and biological materials. However, the literature does not provide any “high-performance thin-layer chromatographic (HPTLC)” assays to determine LMB. In an effort to analyze LMB in commercial pharmaceutical tablets more precisely, accurately, and sustainably than with the normal-phase-HPTLC (NP-HPTLC) approach, a sensitive and greener reverse-phase-HPTLC (RP-HPTLC) method was developed and validated. For NP-HPTLC, an acetone-petroleum ether (40:60 v/v) developing system was used. However, ethanol–water (85:15 v/v) was the developing system for RP-HPTLC. Four different techniques, including the National Environmental Method Index (NEMI), Analytical Eco-Scale (AES), ChlorTox, and Analytical GREENness (AGREE), were used to evaluate the greenness of both procedures. LMB measurement was linear in the 50–500 and 20–1000 ng/band ranges, respectively for NP and RP procedures. RP procedure was more robust (uncertainties = 0.90–0.95 %), accurate (recoveries = 98.24–101.57 %), precise (uncertainties = 0.87–1.00 %), linear (20–1000 ng/band), sensitive (LOD = 0.92 ng/band and LOQ = 2.76 ng/band), and greener over NP procedure. The results of greenness assessment using NEMI (all four circles green), AES (93), ChlorTox (0.88 g), and AGREE (0.89) demonstrated that the RP strategy was greener than NP strategy and all other reported HPLC methods. The fact that both techniques can assess LMB when its degradation products are present implies that they both have characteristics that point to stability-indicating features. 89.24 % and 98.79 %, respectively, were the assay results for LMB in pharmaceutical tablets when utilizing the NP and RP procedures. Based on all validation and greenness metrics, it was found that RP procedure was better than the NP procedure. As a result, it is possible to assess LMB in pharmaceutical products using RP procedure.
Infectious mononucleosis (IM), primarily caused by the Epstein-Barr virus (EBV), is a common viral illness among adolescents and young adults. IM typically presents with symptoms such as fever, lymphadenopathy, and pharyngitis. We present a case of a 32-year-old woman who developed a maculopapular rash following ibuprofen administration, revealing an underlying undiagnosed IM. Laboratory investigations confirmed EBV infection. This represents the first documented case linking non-steroidal anti-inflammatory drugs (NSAIDs) to IM presentation. Awareness of this association is crucial for timely diagnosis and management, especially when evaluating patients with unexplained skin reactions to medications.
European Journal of Pharmaceutical Sciences · مجلد 198 · 106792-106792
Non-alcoholic steatohepatitis (NASH) is characterized by liver inflammation, fat accumulation, and collagen deposition. Due to the limited availability of effective treatments, there is a pressing need to develop innovative strategies. Given the complex nature of the disease, employing combination approaches is essential. Hedgehog signaling has been recognized as potentially promoting NASH, and cholesterol can influence this signaling by modifying the conformation of PTCH1 and SMO activity. HSP90 plays a role in the stability of SMO and GLI proteins. We revealed significant positive correlations between Hedgehog signaling proteins (Shh, SMO, GLI1, and GLI2) and both cholesterol and HSP90 levels. Herein, we investigated the novel combination of the cholesterol-lowering agent lovastatin and the HSP90 inhibitor PU-H71 in vitro and in vivo. The combination demonstrated a synergy score of 15.09 and an MSA score of 22.85, as estimated by the ZIP synergy model based on growth inhibition rates in HepG2 cells. In a NASH rat model induced by thioacetamide and a high-fat diet, this combination therapy extended survival, improved liver function and histology, and enhanced antioxidant defense. Additionally, the combination exhibited anti-inflammatory and anti-fibrotic potential by influencing the levels of TNF-α, TGF-β, TIMP-1, and PDGF-BB. This effect was evident in the suppression of the Col1a1 gene expression and the levels of hydroxyproline and α-SMA. These favorable outcomes may be attributed to the combination's potential to inhibit key Hedgehog signaling molecules. In conclusion, exploring the applicability of this combination contributes to a more comprehensive understanding and improved management of NASH and other fibrotic disorders.
Journal of Infection and Public Health · مجلد 17 (6) · 1013-1022
BACKGROUND: Disability is a serious health issue that can have a significant impact on both physical and mental health. This study attempted to investigate the relationship between depression, quality of life (QOL), and COVID-19 challenges faced by people with disabilities (PwD) from Saudi Arabia. METHODS: A structured interview questionnaire to measure QOL (WHOQOL-BREF) and depression (PHQ-9) was used to conduct a cross-sectional study among PwDs in Saudi Arabia. Binary regression analysis was done using SPSS-IBM and predictors for depression, quality of life and COVID-19 challenges were determined. RESULTS: Of the 111 study samples, two-thirds were male (67.6%), with only one-third employed (34.2%). Most of them (70%) reported moderate to severe disability-related difficulties. Only 28.8% of the samples were satisfied with the physical health domain of the quality of life, whereas 31.5%, 44.1%, and 50.5% were satisfied with the psychological, social, and environmental health domains, respectively. Approximately 62% of the participants had been diagnosed with depression. A significantly higher percentage of participants who had not received COVID-19 vaccination were depressed (P = 0.011), whereas the depression rate was lower among those who received three or four doses of vaccination (P = 0.006). Depression is 4.1 times more likely in people with comorbidities, and disability with increased difficulty (OR: 4.266). Furthermore, vaccinated people had a 5.3-fold higher chance of developing satisfactory QOL. CONCLUSION: Regardless of the type, cause, or duration of disability, the degree of difficulty is a strong predictor of depression and a decrease in quality of life. A multidisciplinary approach is needed to improve the well-being of people with disabilities.
depressionquality of lifepeople with disabilitiesCOVID-19 vaccination
Introduction Post-operative adhesions present a number of difficulties, including intestinal obstruction and infertility, and they frequently require readmission due to adhesion-related problems. Notwithstanding these ramifications, there are surprisingly few thorough national surveys that address surgeons' awareness of adhesives. By assessing Saudi surgeons' knowledge of post-operative adhesions and their use of anti-adhesive medications, this study aims to close this knowledge gap. Methods This study is a cross-sectional observational research study aimed at Saudi Arabian surgeons utilizing a self-administered, semi-structured online questionnaire. The questionnaire was distributed to participants via social media and in-person email using basic random selection. It included adhesion morbidity and prevalence, pre-operative informed consent issues, adhesion preventive viewpoints, and anti-adhesive chemical use. Results There were 111 participants in total, of 41% were experienced surgeons with more than five years of experience. According to the survey, the majority of surgeons occasionally employed anti-adhesive compounds, especially during laparotomies (28%), and 38% never used them during laparoscopies. The study found that participants varied in what they informed patients regarding adhesion complications: 25% of participants informed 5%-10% of the patients about the possible adhesion complications in laparotomy procedures, whereas 26% of participants informed 10-25% of the patients in laparoscopic procedures. Compared with their specialist peers, general surgeons agreed more on the clinical significance of adhesions and prevention. Notably, three-quarters of participants were unclear about when to use anti-adhesive compounds. Conclusion While acknowledging the clinical significance of post-operative adhesions and recognizing the potential for prevention, most surveyed surgeons did not include adhesions as a post-operative complication in informed consent. The study underscores a belief in the efficacy of anti-adhesives yet reveals a widespread lack of clarity regarding specific indications for their use. Recommendations include implementing educational sessions during surgical training to heighten awareness of adhesions as a major post-operative complication and to encourage the appropriate utilization of available barriers and pharmacological anti-adhesive products.
Abstract The study of ramped condition in the context of unsteady incompressible magnetohydrodynamic Casson fluid flow over a moving vertical plate is a complex and important topic in fluid dynamics and heat transfer. This scenario combines several physical phenomena and has practical applications in various engineering and scientific fields. In this study, Casson fluid is considered unsteady under the influence of magnetic field. The fractional mathematical model is proposed by considering the effect of chemical reaction parameter of the flowing fluid. The governing equations are transformed into the dimensionless form and developed fractional models like Caputo-Fabrizio and Atangana-Baleanu Derivative. We used the Laplace transform technique to find the solution of the dimensionless governing equation analytically. The transformed solutions for velocity, energy and momentum balances developed in terms of series. MATHCAD software is being used for numerical computations and the physical attributes of material and fractional parameters are discussed. To analyze their behavior clearly, two-dimensional graphical results are plotted for velocity profile and temperature as well. It has been concluded that the fluid’s velocity are reduced for larger values of the fractional parameter and Prandtl number and is maximum for small values of both parameters. Further, the velocity behavior becomes larger for isothermal condition as compared to ramped conditions.
Case Studies in Thermal Engineering · مجلد 56 · 104240-104240
Marine transportation is a significant contributor to overall energy consumption among transportation sectors and is responsible for producing a considerable amount of greenhouse gases. A potential solution for alternative applications involves implementing combined heat integration, thereby enabling the production of additional utilities and mitigating emissions. The current work introduces an innovative heat integration process for a marine engine, focusing on implementing an optimal thermal matching technique to minimize overall irreversibility in producing liquefied hydrogen and coolant. The process incorporates an organic flash-bi-evaporator cooling cycle, a humidification dehumidification desalination, a polymer electrolyte membrane water electrolysis process, and a Claude cycle. The generated freshwater is delivered to the electrolyzer to produce gaseous hydrogen. This product and the cooling for freezing are utilized in the Claude cycle for hydrogen liquefaction. The study utilizes an advanced thermo-environmental multi-criteria investigation and optimization, considering sensitivity analysis and optimization based on artificial intelligence method. The optimization process incorporates the training and testing of artificial neural networks, NSGA-II method, and TOPSIS decision-making. The primary objective functions include exergetic efficiency and carbon dioxide emission. The findings demonstrate that the specified objectives are computed to be 0.121 and 2.67 kg/MWh, correspondingly. Besides, this condition exhibits a liquefied hydrogen flow rate of 6.44 L/h and a cooling output of 43.61 kW, showing an energy efficiency of 0.1145. Also, the total exergy destruction rate associated with the arranged structure is 124.5 kW. Furthermore, the optimum state reveals an exergoenvironmental index of 0.840 and an exergetic stability factor of 0.869.